Literature DB >> 16631376

Improving mass accuracy of high performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry of intact antibodies.

Himanshu S Gadgil1, Gary D Pipes1, Thomas M Dillon1, Michael J Treuheit1, Pavel V Bondarenko1.   

Abstract

The glycosylation profile of intact antibody due to the galactose and fucose heterogeneity in the N-linked sugars was determined with instrument resolution of 5000 and 10,000. After deconvolution of electrospray ionization mass spectra to complete convergence, several extra peaks appeared in addition to the peaks observed in the original mass spectra. The artificial peaks were avoided if deconvolution was stopped after a smaller number of iterations. A standard antibody was used as an external calibrant to minimize mass measurement errors during long-period experiments. Precision of four consecutive LC/MS measurements of the same antibody was 10 ppm (+/-1.5 Da). By using this approach, the masses of 11 intact antibodies were measured. All antibodies containing N-terminal glutamines had a negative mass shift due to the formation of pyroglutamate (-17 Da). Although the pyroglutamate variant of intact antibody was not resolved from the unmodified variant, this modification led to a mass shift proportional to the percentage of N-terminal pyroglutamate. By accurately measuring the mass shift we were able to quantify the abundance of pyroglutamic acid on intact antibodies. Mass accuracy in measuring different antibodies was below 30 ppm (+/-4 Da). The accurate mass measurement can be an effective tool for monitoring chemical degradations in therapeutic antibodies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16631376     DOI: 10.1016/j.jasms.2006.02.023

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  14 in total

1.  Validation of a peptide mapping method for a therapeutic monoclonal antibody: what could we possibly learn about a method we have run 100 times?

Authors:  J Bongers; J J Cummings; M B Ebert; M M Federici; L Gledhill; D Gulati; G M Hilliard; B H Jones; K R Lee; J Mozdzanowski; M Naimoli; S Burman
Journal:  J Pharm Biomed Anal       Date:  2000-01       Impact factor: 3.935

2.  Signal peptide prediction based on analysis of experimentally verified cleavage sites.

Authors:  Zemin Zhang; William J Henzel
Journal:  Protein Sci       Date:  2004-08-31       Impact factor: 6.725

3.  Stability and CTL activity of N-terminal glutamic acid containing peptides.

Authors:  A Beck; M C Bussat; C Klinguer-Hamour; L Goetsch; J P Aubry; T Champion; E Julien; J F Haeuw; J Y Bonnefoy; N Corvaia
Journal:  J Pept Res       Date:  2001-06

4.  Reversed-phase liquid chromatography/mass spectrometry analysis of reduced monoclonal antibodies in pharmaceutics.

Authors:  Douglas S Rehder; Thomas M Dillon; Gary D Pipes; Pavel V Bondarenko
Journal:  J Chromatogr A       Date:  2005-11-17       Impact factor: 4.759

Review 5.  Effect of glycosylation on antibody function: implications for genetic engineering.

Authors:  A Wright; S L Morrison
Journal:  Trends Biotechnol       Date:  1997-01       Impact factor: 19.536

6.  Cell-free synthesis of amino-terminal L-pyroglutamic acid.

Authors:  G H Jones
Journal:  Biochemistry       Date:  1974-02-26       Impact factor: 3.162

7.  Amino terminal sequences of human immunoglobulin heavy chains.

Authors:  A P Kaplan; L E Hood; W D Terry; H Metzger
Journal:  Immunochemistry       Date:  1971-09

8.  Analysis of glutamine, glutamic acid and pyroglutamic acid in protein hydrolysates by high-performance liquid chromatography.

Authors:  F F Shih
Journal:  J Chromatogr       Date:  1985-03-29

Review 9.  Pyroglutamic acid. Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal.

Authors:  G N Abraham; D N Podell
Journal:  Mol Cell Biochem       Date:  1981-08-11       Impact factor: 3.396

Review 10.  Processing of C-terminal lysine and arginine residues of proteins isolated from mammalian cell culture.

Authors:  R J Harris
Journal:  J Chromatogr A       Date:  1995-06-23       Impact factor: 4.759

View more
  10 in total

1.  Molecular mass analysis of antibodies by on-line SEC-MS.

Authors:  Lowell J Brady; John Valliere-Douglass; Theresa Martinez; Alain Balland
Journal:  J Am Soc Mass Spectrom       Date:  2008-01-04       Impact factor: 3.109

2.  Mass measurement and top-down HPLC/MS analysis of intact monoclonal antibodies on a hybrid linear quadrupole ion trap-Orbitrap mass spectrometer.

Authors:  Pavel V Bondarenko; Tonya P Second; Vlad Zabrouskov; Alexander A Makarov; Zhongqi Zhang
Journal:  J Am Soc Mass Spectrom       Date:  2009-03-28       Impact factor: 3.109

3.  Comparison of LC and LC/MS methods for quantifying N-glycosylation in recombinant IgGs.

Authors:  Sandipan Sinha; Gary Pipes; Elizabeth M Topp; Pavel V Bondarenko; Michael J Treuheit; Himanshu S Gadgil
Journal:  J Am Soc Mass Spectrom       Date:  2008-07-16       Impact factor: 3.109

4.  Electrospray ionization quadrupole ion-mobility time-of-flight mass spectrometry as a tool to distinguish the lot-to-lot heterogeneity in N-glycosylation profile of the therapeutic monoclonal antibody trastuzumab.

Authors:  Carola W N Damen; Weibin Chen; Asish B Chakraborty; Mike van Oosterhout; Jeffrey R Mazzeo; John C Gebler; Jan H M Schellens; Hilde Rosing; Jos H Beijnen
Journal:  J Am Soc Mass Spectrom       Date:  2009-08-07       Impact factor: 3.109

5.  A mechanistic examination of salting out in protein-polymer membrane interactions.

Authors:  Nicholas A Moringo; Logan D C Bishop; Hao Shen; Anastasiia Misiura; Nicole C Carrejo; Rashad Baiyasi; Wenxiao Wang; Fan Ye; Jacob T Robinson; Christy F Landes
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-28       Impact factor: 11.205

6.  Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry.

Authors:  Lei Zhu; Qingcheng Guo; Huaizu Guo; Tao Liu; Yingxin Zheng; Peiming Gu; Xi Chen; Hao Wang; Sheng Hou; Yajun Guo
Journal:  MAbs       Date:  2014       Impact factor: 5.857

7.  Physicochemical and biological characterization of 1E10 anti-idiotype vaccine.

Authors:  Yoan J Machado; Yamilet Rabasa; Raquel Montesinos; José Cremata; Vladimir Besada; Dasha Fuentes; Adolfo Castillo; Kathya R de la Luz; Ana M Vázquez; Martin Himly
Journal:  BMC Biotechnol       Date:  2011-11-22       Impact factor: 2.563

8.  Accumulation of succinimide in a recombinant monoclonal antibody in mildly acidic buffers under elevated temperatures.

Authors:  Grace C Chu; Dirk Chelius; Gang Xiao; Hui K Khor; Sururat Coulibaly; Pavel V Bondarenko
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.580

9.  Computational Studies on the Mechanisms of Nonenzymatic Intramolecular Cyclization of the Glutamine Residues Located at N-Termini Catalyzed by Inorganic Phosphate Species.

Authors:  Tomoki Nakayoshi; Koichi Kato; Eiji Kurimoto; Akifumi Oda
Journal:  ACS Omega       Date:  2020-04-13

10.  Screening of Phosphodiesterase-5 Inhibitors and Their Analogs in Dietary Supplements by Liquid Chromatography-Hybrid Ion Trap-Time of Flight Mass Spectrometry.

Authors:  Unyong Kim; Hyun-Deok Cho; Myung Hee Kang; Joon Hyuk Suh; Han Young Eom; Junghyun Kim; Sumin Seo; Gunwoo Kim; Hye Ryoung Koo; Nary Ha; Un Tak Song; Sang Beom Han
Journal:  Molecules       Date:  2020-06-12       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.